Interferon plus ursodeoxycholic acid versus interferon in the treatment of chronic C viral hepatitis

Minerva Medica

Volumn 88, Issue 5, 1997, Pages 219-225

  Clerici, C ^a  

^a NONE

Author keywords

Antiviral agents; Hepatitis C, viruses; Hepatitys C, therapy; Interferon alfa 2a therapeutic use; Ursodeoxycholic acid therapeutic use

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; RECOMBINANT ALPHA2A INTERFERON; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MIXTURE; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CHOLAGOGUES AND CHOLERETICS; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RECURRENCE; URSODEOXYCHOLIC ACID;

EID: 0030761870     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986;315:1575-8.
2. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP et al. Treatment of chronic hepatitis C with recombinant interferon α. A multicenter randomized, controlled trial. N Engl J Med 1989;321:1501-6.
3. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized double-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-10.